Pluri Inc share price today

(PLUR)

Pluri Inc share price is $5.2 & ₹440.60 as on 6 Dec 2024, 2.30 'hrs' IST

$5.2

▲

0.22

(4.42%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Pluri Inc share price in Dollar and Rupees. Guide to invest in Pluri Inc from India. Also see the sentimental analysis on Indian investors investing in Pluri Inc. Get details on the Indian mutual funds that are investing in Pluri Inc. Get Analyst recommendations and forecasts along with all the Pluri Inc's financials.

Pluri Inc share price movements

$4.97
$5.24
$5.20
4.42%
Downside
Day's Volatility :5.15%
Upside
0.76%
$3.77
$8.48
$5.20
27.45%
Downside
52 Weeks Volatility :55.51%
Upside
38.68%

Pluri Inc Returns

Period	Pluri Inc	Index (Russel 2000)
3 Months	-2.2%	0.0%
6 Months	-8.1%	0.0%
1 Year	8.86%	0.0%
3 Years	-31.32%	-18.1%

Pluri Inc Key Statistics

in dollars & INR

Previous Close	$4.98
Open	$4.97
Today's High	$5.24
Today's Low	$4.97
Market Capitalization	$31.1M
Today's Volume	$24.8K
52 Week High	$8.48
52 Week Low	$3.7728
Revenue TTM	$326.0K
EBITDA	$-21.9M
Earnings Per Share (EPS)	$-4.11
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-206.07%

How to invest in Pluri Inc from India?

It is very easy for Indian residents to invest directly in Pluri Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pluri Inc stock in both rupees (INR) and dollars (USD). Search for Pluri Inc or PLUR on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pluri Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pluri Inc shares which would translate to 0.163 fractional shares of Pluri Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Pluri Inc

10%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Pluri Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 10% more investors are searching Pluri Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Pluri Inc

Renaissance Technologies Corp
0.44%
Values First Advisors Inc
0.25%
Jane Street Group LLC
0.22%
Zurcher Kantonalbank
0.03%
UBS Group AG
0.02%
Morgan Stanley - Brokerage Accounts
0.01%

Analyst Recommendation on Pluri Inc

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Pluri Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Pluri Inc

What analysts predicted

Downside of 23.08%

Current:

$5.20

Target:

$4.00

Insights on Pluri Inc

Increasing Revenue
Revenue is up for the last 3 quarters, 71.0K → 326.0K (in $), with an average increase of 48.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, 279.0K → -5.88M (in $), with an average decrease of 476.7% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.5% return, outperforming this stock by 27.6%

Pluri Inc Technicals Summary

Sell

Neutral

Buy

Pluri Inc is currently in a neutral trading position according to technical analysis indicators.

Pluri Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pluri Inc	10.35%	-8.1%	8.86%	-31.32%	-31.32%
Regeneron Pharmaceuticals, Inc.	-8.09%	-23.99%	-10.23%	20.04%	108.5%
Biontech Se	5.61%	16.8%	14.99%	-61.28%	304.14%
Alnylam Pharmaceuticals, Inc.	-4.63%	65.6%	42.73%	40.34%	109.6%
Vertex Pharmaceuticals Incorporated	-6.83%	-3.58%	31.58%	126.94%	112.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pluri Inc	NA	NA	NA	-0.33	-2.06	-0.31	NA	0.02
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pluri Inc	Buy	$31.1M	-31.32%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	108.5%	18.55	33.61%
Biontech Se	Buy	$28.9B	304.14%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	109.6%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	112.3%	32.84	-4.51%

About Pluri Inc

pluristem therapeutics inc. (nasdaqcm: psti, tase: psti/pltr) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3d) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation. pluristem’s placental expanded (plx) cells are placenta-derived, mesenchymal-like adherent stromal cells that are designed to be administered to patients without the need for tissue or genetic matching. these cells release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine or endocrine manner to facilitate healing of damaged tissues by stimulating the body’s own regenerative mechanisms. the company’s proprietary, 3d expansion technology can be used to grow plx cells in mass quantities with batch-to-batch consistency at pluristem’s fda, ema and pmda-approved, state-of-the art manufacturing facility. pluristem’s first product candi

Organization	Pluri Inc
Employees	106
CEO	Mr. Yaacov Yanay
Industry	Miscellaneous

Management People of Pluri Inc

Name	Title
Mr. Yaacov Yanay	President, CEO & Director
Ms. Liat Zalts	Chief Financial Officer & Treasurer
Mr. Lior Raviv	Chief Technology Officer
Dr. Arthur Machlenkin Ph.D.	Chief Scientific Officer
Ms. Efrat Livne-Hadass	Chief Wellbeing Officer
Ms. Orly Amiran	Chief Quality Officer
Ms. Efrat Kaduri	Chief Business Development Officer of Pharma
Mr. Nimrod Bar Zvi	Chief Commercial Officer
Mr. John Dvor	EVP North America

Important FAQs about investing in Pluri Inc from India :

What is Pluri Inc share price today?

Pluri Inc (PLUR) share price today is $5.20.

Can Indians buy Pluri Inc shares?

Yes, Indians can invest in the Pluri Inc (PLUR) from India.

With INDmoney, you can buy Pluri Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pluri Inc at zero transaction cost.

How can I buy Pluri Inc shares from India?

It is very easy to buy Pluri Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pluri Inc be purchased?

Yes, you can buy fractional shares of Pluri Inc with INDmoney app.

What are the documents required to start investing in Pluri Inc stocks?

To start investing in Pluri Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.